Benefit of ADP Receptor Antagonists in Atherothrombotic Patients: New Evidence

Publisher： Karger

E-ISSN： 1421-9786|11|2|5-10

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.11, Iss.2, 2001-04, pp. : 5-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From CURE to MATCH: ADP Receptor Antagonists as the Treatment of Choice for High-Risk Atherothrombotic Patients

By  

Cerebrovascular Diseases, Vol. 13, Iss. 1, 2002-01 ,pp. : 22-26

Karger

Access to resources Recommend Favorite

Evidence with Antiplatelet Therapy and ADP-Receptor Antagonists

By  

Cerebrovascular Diseases, Vol. 16, Iss. 1, 2003-05 ,pp. : 20-26

Karger

Access to resources Recommend Favorite

Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease

By Storey Robert F.   Wilcox Robert G.   Heptinstall Stan  

Platelets, Vol. 13, Iss. 7, 2002-11 ,pp. : 407-413

Informa Healthcare

Access to resources Recommend Favorite

Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists

By Iyengar Srinivas   Rabbani LeRoy  

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 300-306

Springer Publishing Company

Access to resources Recommend Favorite

DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease

By Heptinstall Stan   Espinosa David Iyu   Manolopoulos Panagiotis   Glenn Jackie   White Ann   Johnson Andrew   Dovlatova Natalia   Fox Sue   May Jane   Hermann David   Magnusson Olafur   Stefansson Kari   Hartman Dan   Gurney Mark  

Platelets, Vol. 19, Iss. 8, 2008-12 ,pp. : 605-613

Informa Healthcare

Access to resources Recommend Favorite